课题基金 / 基金详情

ACTIVE IMMUNOTHERAPY FOR PATIENTS WITH ANAPLASTIC GLIOMA

ACTIVE IMMUNOTHERAPY FOR PATIENTS WITH ANAPLASTIC GLIOMA
间变性神经胶质瘤患者的主动免疫治疗
批准号：
6113790
负责人：
STEVEN K GUDEMAN
金额：
$1.58万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6113790
关键词：
carmustine clinical research clinical trials combination cancer therapy glioma human subject human therapy evaluation immunomodulators levamisole neoplasm /cancer chemotherapy neoplasm /cancer immunotherapy neoplasm /cancer radiation therapy tissue /cell culture

项目摘要

项目成果

STEVEN K GUDEMAN的其他基金

相似基金

相关文献

中文摘要
翻译
这是一项研究主动免疫的抗肿瘤作用与a
英文摘要
This is a study of the antitumor effect of active immunization with a tissue culture glioma cell preparation mixed with adjuvant. Patients were randomized to receive immunization with frozen or unfrozen U-251 glioma cells and treated with levamisole, radiotherapy, and BCNU, or treated conventionally with radiotherapy and BCNU.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BCNU, PROCARBAZINE AND RADIOTHERAPY IN TREATMENT OF ANAPLASTIC GLIOMAS
IMMUNOTHERAPY FOR MALIGNANT GLIOMAS
TREATMENT OF ANAPLASTIC GLIOMAS WITH CONCOMITANT CISPLATIN AND RADIOTHERAPY
PHASE III TRIAL OF CRISNATOL MESYLATE VS BCNU IN BRAIN TUMOR PATIENTS
海外基金